Patents by Inventor Katalin Kataine Fadgyas

Katalin Kataine Fadgyas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE PRODUCTION OF POMALIDOMIDE
    Publication number: 20190040037
    Abstract: The object of the invention relates to a novel group of compounds of general formula 20 that may be used as an intermediate for the production of the pharmaceutical active substance pomalidomide. The object of the invention also relates to a novel, cost-effective, productive method for the production of pomalidomide that can also be implemented on industrial scales via the novel compound of formula 20 according to the invention.
    Type: Application
    Filed: January 19, 2017
    Publication date: February 7, 2019
    Applicant: EGIS GYOGYSZERGYAR ZRT.
    Inventors: Balazs VOLK, Katalin KATAINE FADGYAS, Gyula LUKACS, Maria TOTHNE LAURITZ, Andras DANCSO, Imre KIRALY, Laszlo PALOTAI, Robert KORMANY
  • Crystalline pharmaceutically active ingredients
    Patent number: 9321733
    Abstract: The present invention is related to crystalline forms of rosuvastatin zinc (2:1) salt. The polymorphs are suitable for use as pharmaceutically active ingredients in the treatment of the diseases of the lipid metabolism including hypercholesterolemia, hyperlipidemia, dyslipidemia or atherosclerosis.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: April 26, 2016
    Assignee: EGIS Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag
    Inventors: Imre Markovits, Ferenc Jurak, Gyorgyi Kovanyine Lax, Csaba Hamori, Balazs Havasi, Eva Sipos, Balazs Volk, Zsolt Runge, Krisztina Fodorne Kocsmar, Gyula Lukacs, Katalin Kataine Fadgyas, Monika Mezovari
  • CRYSTALLINE PHARMACEUTICALLY ACTIVE INGREDIENTS
    Publication number: 20130296353
    Abstract: The present invention is related to crystalline forms of rosuvastatin zinc (2:1) salt. The polymorphs are suitable for use as pharmaceutically active ingredients in the treatment of the diseases of the lipid metabolism including hypercholesterolemia, hyperlipidemia, dyslipidemia or atherosclerosis.
    Type: Application
    Filed: November 16, 2011
    Publication date: November 7, 2013
    Applicant: EGIS Gyogyszergyar Nyilvanosan Mukodo Reszvenytar- sasag
    Inventors: Imre Markovits, Ferenc Jurak, Gyorgyi Kovanyine Lax, Csaba Hamori, Balazs Havasi, Eva Sipos, Balazs Volk, Zsolt Runge, Krisztina Fodorne Kocsmar, Gyula Lukacs, Katalin Kataine Fadgyas, Monika Mezovari